Zhongmou Therapeutics
Clinical trials sponsored by Zhongmou Therapeutics, explained in plain language.
-
New eye injection trial aims to slow vision loss from geographic atrophy
Disease control Not yet recruitingThis early-stage trial tests a new drug called AGX-08 for geographic atrophy, an advanced form of age-related macular degeneration that causes blind spots. About 24 people aged 50 and older will receive a single injection into one eye. The main goal is to check safety, but resear…
Phase: EARLY_PHASE1 • Sponsor: Zhongmou Therapeutics • Aim: Disease control
Last updated May 26, 2026 07:42 UTC
-
New injection aims to slow vision loss in rare eye disease
Disease control Not yet recruitingThis early-stage trial tests a new injection called ZM-02 for people with advanced retinitis pigmentosa, a genetic eye disease that causes vision loss. The study will check if the injection is safe and if it can help improve vision or slow further damage. About 21 participants ag…
Phase: PHASE1, PHASE2 • Sponsor: Zhongmou Therapeutics • Aim: Disease control
Last updated May 26, 2026 07:21 UTC